There is another company whose SP quadrupled and now has sunk to less than the starting price - most would know who that company is. They look to have a good product given results from trials but they put out some very (over)optimistic media releases - and somewhat prematurely.
I would rather IMU do what they are doing and be a bit reserved about announcing anything until the ink has dried on phase 2 results. SP should rise significantly - but maybe more sustainably.
Ann: Imugene doses first patient in HER-Vaxx phase 2 trial, page-29
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.5¢ |
Change
-0.002(4.26%) |
Mkt cap ! $386.7M | |||
| Open | High | Low | Value | Volume |
| 4.7¢ | 4.8¢ | 4.4¢ | $890.8K | 19.42M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 176601 | 4.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.6¢ | 969572 | 8 |
View Market Depth
| Last trade - 16.10pm 06/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |
